Medicines open-house rebate agreements 2026-11 – Dorzolamid ATR (EDO) N3

Summary

The tender concerns an open-house agreement for medicines. The contracting authority aims to conclude non-exclusive rebate agreements with suitable pharmaceutical companies for the active substances, combinations, dosage forms, strengths or finished medicinal products listed in the relevant lot. The contract term is generally up to 20 months, starting no earlier than 1 August 2026 and ending no later than 31 March 2028. Participation is possible at any time during the contract period. The notice does not provide precise qualification or exclusion requirements; these must be checked in the tender documents.